About Us
Our
Medicines
- YCANTH
Product
Candidates
Investors &
Media
Careers

Menu

About Us
Our
Medicines
- YCANTH
Product
Candidates
Investors &
Media
Careers

Breaking News:
Verrica announced the approval of YCANTH™ (cantharidin) topical solution 0.7%

Event Details

Bank of America Merrill Lynch 2019 Healthcare Conference

May 14, 2019 5:35 pm

Click here for webcast

Supporting Materials

Bank of America Merrill Lynch 2019 Healthcare Conference

About Us

Our Company
Leadership
Compliance
Contact
Medical Education Grants

Our Medicines

YCANTH

Product Candidates

Pipeline VP-102
Pipeline VP-103
Pipeline VP-315
R & D
Key Publications

Investors & Media

Investor Overview
Press Releases
Analyst Coverage
Presentations & Events
Stock Information
SEC Filings
Corporate Governance
Investor FAQs
Investor Connection

Careers

Terms of Use
Privacy Policy
Patent Notices

Twitter Linkedin-in Facebook-f

© 2023 Verrica Pharmaceuticals.

VIRTUAL KOL EVENT

Discussing the Approval of YCANTH™ (Cantharidin) Topical Solution for the Treatment of Molluscum

October 11th, 2023 | 11:00 AM ET

Click to Register & Attend